Lutetium 177 PSMA Therapy | Advanced Prostate Cancer Treatment at KUTRRH

 Kenyatta University Teaching, Referral & Research Hospital (KUTRRH) has achieved a remarkable medical breakthrough—becoming the first public hospital in East Africa to offer Lutetium‑177 PSMA targeted radiation therapy, an innovative treatment giving new hope to patients with advanced prostate cancer.
This milestone strengthens KUTRRH’s position as a regional leader in modern cancer treatment and expands access to life-extending therapies previously available only abroad or in private facilities.

What Makes Lutetium‑177 PSMA Therapy a Breakthrough?

Learn more: https://shorturl.at/bjaXu

Switch Language »